Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.22.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2021
STOCK-BASED COMPENSATION.  
Schedule of Common Stock Options The following table summarizes information related to the Company’s common stock options:

    

Weighted

    

Average

    

    

Weighted

Remaining

Number

Average

Contractual

Aggregate

of Stock

Exercise

Term

Intrinsic

Options

Price

(in years)

Value

Options outstanding at January 1, 2021

 

3,183,708

$

1.71

 

  

 

  

Granted

 

315,620

 

7.25

 

  

 

  

Exercised

 

(201,039)

 

1.97

 

  

 

  

Canceled/Forfeited

 

(76,333)

 

3.33

 

  

 

  

Expired

 

 

 

  

 

  

Options outstanding at December 31, 2021

 

3,221,956

$

2.19

 

5.12

$

31,947,381

Options exercisable at December 31, 2021

 

2,601,337

$

1.67

 

4.27

$

27,170,404

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Option valuation weighted-average assumptions were as follows:

Year Ended December 31, 

    

2021

2020

2019

Expected volatility

 

65.99

%  

60.78

%

46.17

%

Expected dividend yield

 

%  

%

%

Expected term (in years)

 

6.00

 

5.94

5.94

Weighted average risk-free rate

 

0.97

%  

0.41

%

1.87

%

Schedule of compensation expense Compensation expense is as follows for the three years ended December 31, 2021:

(In thousands)

Year Ended December 31, 

Compensation Expense

2021

2020

2019

Stock options

$

649

$

405

$

348

Restricted stocks and Performance-based shares

 

317

 

 

$

966

$

405

$

348

Schedule of weighted-average grant date fair value of options granted

Therefore, the weighted-average grant date fair value of options granted is as follows for the three years ended December 31, 2021:

Year Ended December 31, 

2021

2020

2019

Weighted average grant date fair value

$

5.68

$

0.95

$

0.94